Logo image of KROS

KEROS THERAPEUTICS INC (KROS) Stock Analyst Ratings

NASDAQ:KROS - Nasdaq - US4923271013 - Common Stock - Currency: USD

11.02  -0.01 (-0.09%)

After market: 10.9401 -0.08 (-0.73%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to KROS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 30.8. This target is 179.53% above the current price.
KROS was analyzed by 20 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about KROS.
In the previous month the buy percentage consensus was at a similar level.
KROS was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
KROS Historical Analyst RatingsKROS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -56 -51 -46 -41 -36 -31 -26 -21 -16 -11 -6 -1 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 11.0215.1530.6030.8049.35 - 37.48% 177.68% 179.53% 347.82%
KROS Current Analyst RatingKROS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2025-01-21 Cantor Fitzgerald Downgrade Overweight -> Neutral
2025-01-17 Guggenheim Reiterate Neutral -> Neutral
2025-01-17 Wedbush Downgrade Outperform -> Neutral
2025-01-17 Piper Sandler Maintains Overweight -> Overweight
2025-01-16 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2025-01-16 Oppenheimer Maintains Outperform -> Outperform
2024-12-23 Truist Securities Maintains Buy -> Buy
2024-12-16 Guggenheim Downgrade Buy -> Neutral
2024-12-16 Oppenheimer Maintains Outperform -> Outperform
2024-12-13 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2024-12-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-12 TD Cowen Downgrade Buy -> Hold
2024-12-12 William Blair Downgrade Outperform -> Market Perform
2024-12-12 BTIG Downgrade Buy -> Neutral
2024-12-11 Wells Fargo Maintains Overweight -> Overweight
2024-12-05 Guggenheim Maintains Buy -> Buy
2024-12-04 Guggenheim Reiterate Buy -> Buy
2024-11-22 Cantor Fitzgerald Reiterate Overweight
2024-11-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-24 Cantor Fitzgerald Reiterate Overweight
2024-10-16 ScotiaBank Initiate Sector Outperform
2024-09-23 Guggenheim Initiate Buy
2024-09-12 B of A Securities Maintains Buy -> Buy
2024-06-25 Oppenheimer Initiate Outperform
2024-06-18 Truist Securities Maintains Buy -> Buy
2024-06-18 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-09 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-27 Piper Sandler Maintains Overweight -> Overweight
2024-03-13 Truist Securities Reiterate Buy -> Buy
2024-03-01 HC Wainwright & Co. Reiterate Buy -> Buy